Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 751

1.

ASO Author Reflections: Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.

Iijima M, Yokobori T, Mogi A, Shirabe K, Kuwano H.

Ann Surg Oncol. 2019 Nov 11. doi: 10.1245/s10434-019-07880-0. [Epub ahead of print] No abstract available.

PMID:
31712924
2.

Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.

Kurozumi S, Alsaeed S, Orah N, Miligy IM, Joseph C, Aljohani A, Toss MS, Fujii T, Shirabe K, Green AR, Aleskandarany MA, Rakha EA.

Breast Cancer Res Treat. 2019 Nov 9. doi: 10.1007/s10549-019-05488-2. [Epub ahead of print]

PMID:
31707510
3.

ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer.

Nakazawa N, Yokobori T, Turtoi A, Shirabe K.

Ann Surg Oncol. 2019 Nov 6. doi: 10.1245/s10434-019-08057-5. [Epub ahead of print] No abstract available.

PMID:
31696394
4.

Fairly rare small-diameter hepatocellular carcinoma with right adrenal gland metastasis having an inferior vena cava tumor thrombus: a case report.

Igarashi T, Harimoto N, Matsumura N, Sugiyama M, Araki K, Yokobori T, Kosone T, Takagi H, Aishima S, Yokoo H, Shirabe K.

Surg Case Rep. 2019 Nov 6;5(1):170. doi: 10.1186/s40792-019-0705-7.

PMID:
31696344
5.

Evaluation of the use of intraoperative real-time virtual sonography with sonazoid enhancement for detecting small liver metastatic lesions after chemotherapy in hepatic resection.

Araki K, Harimoto N, Muranushi R, Hoshino K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K.

J Med Invest. 2019;66(3.4):319-323. doi: 10.2152/jmi.66.319.

6.

FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.

Watanabe A, Harimoto N, Yokobori T, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Handa T, Oyama T, Higuchi T, Shirabe K.

Int J Clin Oncol. 2019 Oct 14. doi: 10.1007/s10147-019-01557-0. [Epub ahead of print]

PMID:
31612350
7.

STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.

Osone K, Yokobori T, Katayama C, Takahashi R, Kato R, Tatsuski H, Takada T, Yajima R, Motegi Y, Ogawa H, Fujii T, Ojima H, Nakamura J, Yao T, Shirabe K, Kuwano H.

Oncol Lett. 2019 Nov;18(5):4712-4718. doi: 10.3892/ol.2019.10814. Epub 2019 Sep 5.

8.

Fucosylated α1-acid glycoprotein as a biomarker to predict prognosis following tumor immunotherapy of patients with lung cancer.

Yokobori T, Yazawa S, Asao T, Nakazawa N, Mogi A, Sano R, Kuwano H, Kaira K, Shirabe K.

Sci Rep. 2019 Oct 10;9(1):14503. doi: 10.1038/s41598-019-51021-2.

9.

High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors.

Nakazawa N, Yokobori T, Kaira K, Turtoi A, Baatar S, Gombodorj N, Handa T, Tsukagoshi M, Ubukata Y, Kimura A, Kogure N, Ogata K, Maeno T, Sohda M, Yajima T, Shimizu K, Mogi A, Kuwano H, Saeki H, Shirabe K.

Ann Surg Oncol. 2019 Sep 30. doi: 10.1245/s10434-019-07878-8. [Epub ahead of print]

PMID:
31571056
10.

Global standardization of laparoscopic liver resection and challenges for the future.

Araki K, Harimoto N, Shirabe K.

Hepatobiliary Surg Nutr. 2019 Aug;8(4):386-388. doi: 10.21037/hbsn.2019.02.08. No abstract available.

11.

Changes in Skin Perfusion Pressure After Hyperbaric Oxygen Therapy Following Revascularization in Patients With Critical Limb Ischemia: A Preliminary Study.

Nakamura H, Makiguchi T, Atomura D, Yamatsu Y, Shirabe K, Yokoo S.

Int J Low Extrem Wounds. 2019 Sep 3:1534734619868925. doi: 10.1177/1534734619868925. [Epub ahead of print]

PMID:
31478408
12.

Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment.

Araki K, Harimoto N, Kubo N, Watanabe A, Igarashi T, Tsukagoshi M, Ishii N, Tsushima Y, Shirabe K.

HPB (Oxford). 2019 Aug 30. pii: S1365-182X(19)30687-2. doi: 10.1016/j.hpb.2019.08.002. [Epub ahead of print]

PMID:
31477460
13.

Optimal indications for an intercostal port for the superior segments in laparoscopic partial liver resection.

Araki K, Harimoto N, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K.

Asian J Endosc Surg. 2019 Aug 29. doi: 10.1111/ases.12753. [Epub ahead of print]

PMID:
31468734
14.

High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.

Hagiwara K, Harimoto N, Yokobori T, Muranushi R, Hoshino K, Gantumur D, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Shirabe K.

Ann Surg Oncol. 2019 Aug 28. doi: 10.1245/s10434-019-07708-x. [Epub ahead of print]

PMID:
31463696
15.

Four stay-sutures method: a simplified hand-sewn purse-string suture in laparoscopic circular-stapled esophagojejunostomy.

Sano A, Ojima H, Ogawa A, Ogata K, Saito K, Fukasawa T, Sohda M, Fukai Y, Mochida Y, Fukuchi M, Naitoh H, Saeki H, Shirabe K.

Surg Today. 2019 Aug 27. doi: 10.1007/s00595-019-01867-w. [Epub ahead of print]

PMID:
31456000
16.

Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801).

Shiba S, Okamoto M, Kiyohara H, Ohno T, Kaminuma T, Asao T, Ojima H, Shirabe K, Kuwano H, Nakano T.

Front Oncol. 2019 Jul 31;9:702. doi: 10.3389/fonc.2019.00702. eCollection 2019.

17.

Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.

Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.

Pancreatology. 2019 Sep;19(6):897-902. doi: 10.1016/j.pan.2019.08.003. Epub 2019 Aug 7.

PMID:
31409525
18.

Long-term complete response in a patient with postoperative recurrent ALK-rearranged lung adenocarcinoma treated with crizotinib: A case report.

Kosaka T, Yajima T, Yamaki E, Nakazawa S, Tomizawa K, Onozato R, Yamazaki A, Hirato J, Yatabe Y, Shimizu K, Mogi A, Shirabe K.

Mol Clin Oncol. 2019 Sep;11(3):309-312. doi: 10.3892/mco.2019.1892. Epub 2019 Jul 3.

19.

A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study.

Shiba S, Shibuya K, Katoh H, Kaminuma T, Miyazaki M, Kakizaki S, Shirabe K, Ohno T, Nakano T.

Radiat Oncol. 2019 Aug 2;14(1):137. doi: 10.1186/s13014-019-1347-4.

20.

Low IRBIT Levels Are Associated With Chemo-resistance in Gastric Cancer Patients.

Nakazawa N, Ogata K, Yokobori T, Ide M, Baatar S, Ubukata Y, Kimura A, Kogure N, Sohda M, Kuwano H, Saeki H, Shirabe K.

Anticancer Res. 2019 Aug;39(8):4111-4116. doi: 10.21873/anticanres.13569.

PMID:
31366495
21.

Preoperative Mac-2 binding protein glycosylation isomer level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma.

Ishii N, Harimoto N, Araki K, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Yamanaka T, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Shirabe K.

Hepatol Res. 2019 Jul 24. doi: 10.1111/hepr.13412. [Epub ahead of print]

PMID:
31339606
22.

Nationwide Molecular Epidemiology of Measles Virus in Japan Between 2008 and 2017.

Seki F, Miyoshi M, Ikeda T, Nishijima H, Saikusa M, Itamochi M, Minagawa H, Kurata T, Ootomo R, Kajiwara J, Kato T, Komase K, Tanaka-Taya K, Sunagawa T, Oishi K, Okabe N, Kimura H, Suga S, Kozawa K, Otsuki N, Mori Y, Shirabe K, Takeda M; Measles Virus Surveillance Group of Japan; Technical Support Team for Measles Control in Japan.

Front Microbiol. 2019 Jul 4;10:1470. doi: 10.3389/fmicb.2019.01470. eCollection 2019.

23.

Impact of skeletal muscle mass volume on surgical site infection in free flap reconstruction for oral cancer.

Makiguchi T, Yamaguchi T, Nakamura H, Suzuki K, Harimoto N, Shirabe K, Yokoo S.

Microsurgery. 2019 Oct;39(7):598-604. doi: 10.1002/micr.30494. Epub 2019 Jul 22.

PMID:
31328303
24.

β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.

Kurozumi S, Kaira K, Matsumoto H, Hirakata T, Yokobori T, Inoue K, Horiguchi J, Katayama A, Koshi H, Shimizu A, Oyama T, Sloan EK, Kurosumi M, Fujii T, Shirabe K.

Breast Cancer Res Treat. 2019 Oct;177(3):603-610. doi: 10.1007/s10549-019-05341-6. Epub 2019 Jul 9.

PMID:
31290053
25.

FF-10832 enables long survival via effective gemcitabine accumulation in a lethal murine peritoneal dissemination model.

Higuchi T, Yokobori T, Takahashi R, Naito T, Kitahara H, Matsumoto T, Kakinuma C, Hagiwara S, Kuwano H, Shirabe K, Asao T.

Cancer Sci. 2019 Sep;110(9):2933-2940. doi: 10.1111/cas.14123. Epub 2019 Aug 1.

26.

Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor.

Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.

Pancreas. 2019 Aug;48(7):943-947. doi: 10.1097/MPA.0000000000001355.

PMID:
31268980
27.

Multi-season analyses of causative pathogens in children hospitalized with asthma exacerbation.

Abe N, Yasudo H, Fukano R, Nakamura T, Okada S, Wakiguchi H, Okazaki F, Shirabe K, Toda S, Okamoto R, Ouchi K, Ohga S, Hasegawa S.

Pediatr Allergy Immunol. 2019 Nov;30(7):724-731. doi: 10.1111/pai.13102. Epub 2019 Aug 12.

PMID:
31251831
28.

Peritransplant kinetics of Mac-2-binding protein glycosylation isomer levels in living donor liver transplantation: its implication of posttransplant small-for-size syndrome.

Uchiyama H, Shirabe K, Bekki Y, Toshima T, Harimoto N, Ikegami T, Yoshizumi T.

Transl Gastroenterol Hepatol. 2019 May 25;4:41. doi: 10.21037/tgh.2019.05.08. eCollection 2019.

29.

Will minimally invasive sleeve resection become the future trend for treatment of advanced lung cancer?

Kosaka T, Shimizu K, Nakazawa S, Obayashi K, Ohtaki Y, Kawatani N, Ibe T, Yajima T, Mogi A, Shirabe K.

J Thorac Dis. 2019 Apr;11(4):1085-1087. doi: 10.21037/jtd.2019.02.95. No abstract available.

30.

Cytokine Profile in a Patient With Enterovirus D68-Associated Acute Flaccid Myelitis.

Hidaka I, Matsushige T, Inoue H, Hoshide M, Shirabe K, Hasegawa S.

Pediatr Neurol. 2019 Oct;99:88-90. doi: 10.1016/j.pediatrneurol.2019.04.011. Epub 2019 Apr 26. No abstract available.

31.

Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.

Sohda M, Miyazaki T, Sakai M, Kumakura Y, Honjyo H, Hara K, Tanaka N, Yokobori T, Shirabe K.

Anticancer Res. 2019 Jun;39(6):3167-3175. doi: 10.21873/anticanres.13454.

PMID:
31177163
32.

Assessment of the skin tissue structure using an ultrasonic diagnostic imaging device in patients undergoing open surgery.

Oohashi F, Suto T, Matsui H, Shirabe K, Uchida Y.

Skin Res Technol. 2019 Nov;25(6):821-829. doi: 10.1111/srt.12727. Epub 2019 May 29.

PMID:
31144387
33.

A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.

Kurozumi S, Joseph C, Sonbul S, Alsaeed S, Kariri Y, Aljohani A, Raafat S, Alsaleem M, Ogden A, Johnston SJ, Aleskandarany MA, Fujii T, Shirabe K, Caldas C, Ashankyty I, Dalton L, Ellis IO, Desmedt C, Green AR, Mongan NP, Rakha EA.

Br J Cancer. 2019 Jun;120(12):1129-1136. doi: 10.1038/s41416-019-0486-6. Epub 2019 May 22.

PMID:
31114020
34.

Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.

Kurozumi S, Yamaguchi Y, Matsumoto H, Kurosumi M, Hayashi SI, Fujii T, Horiguchi J, Shirabe K, Inoue K.

PLoS One. 2019 May 21;14(5):e0217279. doi: 10.1371/journal.pone.0217279. eCollection 2019.

35.

Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.

Ogawa H, Kaira K, Motegi Y, Yokobori T, Takada T, Katoh R, Osone K, Takahashi R, Katayama C, Oyama T, Kanai Y, Yao T, Asao T, Kuwano H, Shirabe K.

Anticancer Res. 2019 May;39(5):2535-2543. doi: 10.21873/anticanres.13375.

PMID:
31092450
36.

Evaluation of KRAS Mutation Status in a Patient With Concomitant Pancreatic Neuroendocrine Neoplasm and Intraductal Papillary Mucinous Neoplasm.

Igarashi T, Harimoto N, Nobusawa S, Yoshida Y, Yamanaka T, Hagiwara K, Hoshino K, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Yokobori T, Yokoo H, Shirabe K.

Pancreas. 2019 May/Jun;48(5):e34-e35. doi: 10.1097/MPA.0000000000001286. No abstract available.

PMID:
31090662
37.

Long-term donor quality of life after living donor liver transplantation in Japan.

Morooka Y, Umeshita K, Taketomi A, Shirabe K, Yoshizumi T, Yamamoto M, Shimamura T, Oshita A, Ohdan H, Kawagishi N, Hagiwara K, Eguchi H, Nagano H.

Clin Transplant. 2019 Jun;33(6):e13584. doi: 10.1111/ctr.13584. Epub 2019 May 9.

PMID:
31074181
38.

Current status of hepatopulmonary syndrome in liver transplantation in Japan: a Japanese multicenter analysis.

Kotera Y, Egawa H, Ogata S, Teramukai S, Kaido T, Shirabe K, Taketomi A, Takada Y, Yamamoto M, Yamaue H; Japanese Society of Hepato-Biliary-Pancreatic Surgery.

J Hepatobiliary Pancreat Sci. 2019 Jul;26(7):292-299. doi: 10.1002/jhbp.632. Epub 2019 Jun 10.

PMID:
31069999
39.

Hepatic pleomorphic leiomyosarcoma after surgery for gastric gastrointestinal stromal tumor: a case report.

Muranushi R, Hoshino K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Harimoto N, Ikota H, Shibuya K, Miyazaki M, Shirabe K.

Surg Case Rep. 2019 Apr 16;5(1):62. doi: 10.1186/s40792-019-0622-9.

40.

Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.

Sakai M, Sohda M, Saito H, Kuriyama K, Yoshida T, Kumakura Y, Hara K, Yokobori T, Miyazaki T, Murata K, Noda SE, Nakano T, Kuwano H, Shirabe K.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1121-1126. doi: 10.1007/s00280-019-03835-0. Epub 2019 Apr 9.

PMID:
30972455
41.

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report.

Hoshino K, Harimoto N, Muranushi R, Araki K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Yokobori T, Shirabe K.

Surg Case Rep. 2019 Apr 10;5(1):56. doi: 10.1186/s40792-019-0619-4.

42.

Pulmonary Artery Compression Facilitates Intersegmental Border Visualization.

Yajima T, Shimizu K, Mogi A, Ibe T, Ohtaki Y, Obayashi K, Nakazawa S, Kawatani N, Shirabe K.

Ann Thorac Surg. 2019 Aug;108(2):e141-e143. doi: 10.1016/j.athoracsur.2019.02.067. Epub 2019 Apr 2.

PMID:
30951697
43.

Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.

Kurozumi S, Joseph C, Raafat S, Sonbul S, Kariri Y, Alsaeed S, Pigera M, Alsaleem M, Nolan CC, Johnston SJ, Aleskandarany MA, Ogden A, Fujii T, Shirabe K, Martin SG, Alshankyty I, Mongan NP, Ellis IO, Green AR, Rakha EA.

Breast Cancer Res Treat. 2019 Jul;176(1):63-73. doi: 10.1007/s10549-019-05216-w. Epub 2019 Apr 2.

PMID:
30941650
44.

Medial-basal segment (S7)-sparing right basal segmentectomy.

Yajima T, Shimizu K, Mogi A, Kosaka T, Nakazawa S, Shirabe K.

Gen Thorac Cardiovasc Surg. 2019 Apr 1. doi: 10.1007/s11748-019-01116-4. [Epub ahead of print]

PMID:
30937818
45.

Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.

Iijima M, Yokobori T, Mogi A, Shimizu K, Yajima T, Kosaka T, Ohtaki Y, Obayashi K, Nakazawa S, Gombodorj N, Tsukagoshi M, Shirabe K, Kuwano H.

Ann Surg Oncol. 2019 Jun;26(6):1744-1750. doi: 10.1245/s10434-019-07268-0. Epub 2019 Mar 28.

PMID:
30924018
46.

Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.

Shimizu K, Goto Y, Kawabata-Iwakawa R, Ohtaki Y, Nakazawa S, Yokobori T, Obayashi K, Kawatani N, Yajima T, Kaira K, Mogi A, Hirato J, Nishiyama M, Shirabe K.

Ann Thorac Surg. 2019 Jul;108(1):235-243. doi: 10.1016/j.athoracsur.2019.02.040. Epub 2019 Mar 22.

PMID:
30910656
47.

It is time to abandon the Milan criteria.

Yoshizumi T, Shirabe K, Mori M.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):56-58. doi: 10.21037/hbsn.2018.10.08. No abstract available.

48.

Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis.

Kurozumi S, Matsumoto H, Kurosumi M, Inoue K, Fujii T, Horiguchi J, Shirabe K, Oyama T, Kuwano H.

Oncol Lett. 2019 Mar;17(3):2647-2656. doi: 10.3892/ol.2019.9938. Epub 2019 Jan 16.

49.

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas.

Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, Yamane A, Kaira K, Yokobori T, Nagashima T, Obayashi K, Nakazawa S, Iijima M, Kosaka T, Yajima T, Mogi A, Kuwano H, Shirabe K, Nishiyama M.

Oncotarget. 2019 Feb 12;10(13):1306-1319. doi: 10.18632/oncotarget.26657. eCollection 2019 Feb 12.

50.

The Association Between Documentation of Koplik Spots and Laboratory Diagnosis of Measles and Other Rash Diseases in a National Measles Surveillance Program in Japan.

Kimura H, Shirabe K, Takeda M, Kobayashi M, Tsukagoshi H, Okayama K, Ryo A, Nagasawa K, Okabe N, Minagawa H, Kozawa K.

Front Microbiol. 2019 Feb 18;10:269. doi: 10.3389/fmicb.2019.00269. eCollection 2019.

Supplemental Content

Loading ...
Support Center